China based WuXi Biologics has entered into a collaboration with Adagene Inc. to support supply of Adagene's products fo...
MicuRx Pharmaceuticals announced the Global Partnership Program " Combating Antibiotic Resistant Bacteria Accelerator" (...
Chengdu-based consumer genetic testing startup 23Mofang has raised Rmb100 million ($15.8 million) in a Series B funding ...
WuXi Biologics, a Hong Kong-listed company, received Asia's CMO of 2017 at the 8th Annual BioPh...
The Hong Kong Polytechnic University (PolyU) has joined forces with the Fraunhofer-Gesellschaft (Fraunhofer) and the Kar...
Tianjin, China based Tasly Pharmaceutical Group is planning to list its biopharma unit in Hong Kong to raise about $1 bi...
China based CARsgen Therapeutics, a leading immune-oncology company focusing on the development of CAR-T therapies, has ...
Chinese e-commerce giant Alibaba has opened its first joint research institute outside China in Singapore, in a collabor...
Early stage Chinese bispecific biotech EpimAb Biotherapeutics has roped in Bin Peng, M.D., Ph.D, as its first chief medi...
Hong Kong Science and Technology Parks Corporation (HKSTP) plans to focus on biotechnology and artificial intelligence a...
MabSpace is a global biotechnology company focused on discovering and developing innovative antibody therapeutics using ...
Alma Lasers, a subsidiary of Sisram Medical Ltd the leading global innovator of laser light-based, radiofrequency and ul...
A WuXi AppTec group company, STA Pharmaceutical Co., the leading open-access capability and technology platform for smal...
Two institutes from Ethiopia and China have signed a memorandum of understanding (MoU) on scientific and technological c...
Tetraphase Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing novel antibiotic...
The biopharmaceutical company Mologen recently announced the signing of a license deal for the Chinese territory and a g...
China’s state-controlled drugmaker Harbin Pharmaceutical Group Holding Co plans to buy an about 40 percent st...
Industry veteran, Michael Glynn, has joined CANbridge Life Sciences' advisory team, where he will provide lead...
